9–13 Sept 2024
ETH Zürich
Europe/Zurich timezone

【925】Improving oral vaccine efficacy through the study of antibody–bacterial glycan interactions and gut dynamics

11 Sept 2024, 15:45
15m
ETF C 1

ETF C 1

Talk Biophysics and Soft Matter Biophysics and Soft Matter

Speaker

Dr Milad Radiom (ETH-Zürich)

Description

Interactions between mucosal secretory IgA (sIgA) and bacterial surface glycan (O-antigen) protect against Salmonella Typhimurium (S. Tm) infection. sIgA binding induces "enchained growth," reducing the number of single bacteria and enhancing enchained pathogen clearance in fecal stream. Half-life of long bacterial chains depends on detailed force-dependent kinetics of sIgA–O-antigen interactions, mechanical gut stress, and bacterial division rate. Using AFM and SPR, we quantified sIgA–O-antigen interactions parameters which were then integrated into a model that simulated bacterial chain stability against gut stress. By relating sIgA variants' binding characteristics to bacterial chain stability, we aim to optimize oral vaccine effectiveness against bacterial surface glycans.

Author

Dr Milad Radiom (ETH-Zürich)

Co-authors

Ms Anna Huhn (University of Oxford) Prof. Emma Slack (ETH-Zürich) Prof. Omer Dushek (University of Oxford) Prof. Raffaele Mezzenga (ETH-Zürich) Ms Suwannee Ganguillet (ETH-Zürich) Mr Tom Kloter (ETH-Zürich) Dr Yagmur Turgay (ETH-Zürich)

Presentation materials